Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $46.38 USD
Change Today +1.12 / 2.47%
Volume 675.2K
IPXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Larry Hsu Ph.D.

AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 2 different industries.

See Board Relationships
65$4,056,135
As of Fiscal Year 2014

Background*

Dr. Larry Hsu, Ph.D. served as the Chief Executive Officer of Impax Laboratories Inc., since October 1, 2006 until April 29, 2014 and served as its President since December 1999 until April 29, 2014. Dr. Hsu served as the Chief Operating Officer of Impax Laboratories Inc. from December 1999 to January 2003. Dr. Hsu co-founded Impax Pharmaceuticals Inc., a subsidiary of Impax Laboratories Inc. in 1994 and served as its Chief Executive Officer, President and Chief Operating ...

Read Full Background

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-240-6096

Board Members Memberships*

1999-Present
Director
2015-Present
Director

Education*

PhD
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$364,507
Total Annual Compensation$364,507

Stock Options*

Restricted Stock Awards$121,152
All Other Compensation$3,083,200
Exercisable Options802,500
Exercisable Options Value$15,355,275
Unexercisable Options11,500
Unexercisable Options Value$74,060
Total Value of Options$15,429,335
Total Number of Options814,000

Total Compensation*

Total Annual Cash Compensation$3,815,613
Total Short Term Compensation$364,507
Other Long Term Compensation$3,204,352
Total Calculated Compensation$4,056,135
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $46.38 USD +1.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Glenn Mario Saldanha Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination & Remuneration Committee and Member of Shareholders/Investors Grievance Committee
Glenmark Pharmaceuticals Ltd.
57.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.